A Study Evaluating the Safety and Efficacy of VX-440 Combination Therapy in Subjects With Cystic Fibrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Cystic Fibrosis
Interventions
DRUG

TEZ

DRUG

IVA

DRUG

VX-440

DRUG

Matched Placebo

Trial Locations (40)

Unknown

The Arizona Board of Regents on behalf of the University of Arizona, Tucson

Stanford University, Palo Alto

University of California, San Francisco

National Jewish Health, Denver

Joe Di Maggio Cystic Fibrosis & Pulmonary Center, Hollywood

Central Florida Pulmonary Group, Orlando

St. Luke's CF Center of Idaho, Boise

Cystic Fibrosis Center of Chicago, Glenview

The Johns Hopkins Hospital, Baltimore

Boston Children's Hospital, Boston

Massachusetts General Hospital Cystic Fibrosis Center, Boston

University of Minnesota, Minneapolis

New York Medical College, Hawthorne

Long Island Jewish Medical Center, New Hyde Park

Columbia University Medical Center, New York

Nationwide Children's Hospital, Columbus

Respiratory Diseases of Children and Adolescents, Oklahoma City

UPMC OSPARS Children's Hospital of Pittsburgh, Pittsburgh

Sanford Children's Specialty Clinic Sanford Research USD, Sioux Falls

The University of Texas Southwestern Center, Dallas

Children's Hospital of the Kings Daughters, Norfolk

Seattle Children's Hospital, Seattle

Royal Adelaide Hospital, Adelaide

Prince Charles Hospital, Chermside

John Hunter Hospital & Hunter Medical Research Institute, New Lambton Heights

Medizinische Universitat Innsbruck, Innsbruck

Universitair Ziekenhuis Brussel, Brussels

Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven

St. Paul's Hopsital, Vancouver

St. Michael's Hospital, Toronto

Juliane Marie Center, Righospitalet, Copenhagen

University Hospital Cologne, Cologne

Mukeviszidose-Zentrum am Universtitatsklinikum Jena, Jena

Pneumologische Praxis Pasing, München

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan

Hospital Universitari Vall d´Hebron Servicio de Broncoscopia, Barcelona

Hospital Universitario Virgen del Rocio, Seville

Heart of England NHS Foundation Trust, Birmingham

Royal Brompton & Harefield NHS Foundation Trust, Royal Brompton Hospital, London

Southampton University Hospitals NHS Foundation Trust, Southampton

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY

NCT02951182 - A Study Evaluating the Safety and Efficacy of VX-440 Combination Therapy in Subjects With Cystic Fibrosis | Biotech Hunter | Biotech Hunter